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nonprofessional antigen-presenting cells in modulating renalIFN-g and LPS differentially modulate class II MHC and B7-1
immune responses.expression on murine renal tubular epithelial cells.
Background. We have investigated inducible class II major
histocompatibility complex (MHC) and B7 expression on pri-
mary murine renal tubular epithelial cells, called F1K cells,
Studies in inflammatory renal diseases, such as allo-and examined their role in activating nephritogenic T cells
graft rejection, tubulointerstitial nephritis, and autoim-derived from kidneys of animals with autoimmune glomerulo-
nephritis. mune glomerulonephritis, have suggested a prominent
Methods. Class II MHC, class II transactivator, and costimu- role for T-cell–mediated events in injurious renal im-
latory molecule expression were evaluated in untreated and mune responses [1–3]. Current models of cell-mediated
cytokine-treated F1K cells by Northern hybridization and flow
interactions suggest that in vivo T-cell activation occurscytometry. Cell-surface B7-1 expression was evaluated in vitro
as a result of coordinated signaling events initiated afterby immunoprecipitation and in vivo by immunohistochemistry.
T-cell activation studies were then performed to assess the cell-surface receptors bind to appropriate counter-recep-
functional significance of B7-1 expression on F1K cells. tors on an antigen-presenting cell (APC) or a target cell
Results. Coincubation of F1K cells with interferon (IFN)-g [4]. Although antigen-specific T-cell activation is initi-and lipopolysaccharide (LPS) significantly decreased IFN-g–
ated by contact between the T-cell receptor (TCR) forinduced class II MHC expression, by both fluorescence-acti-
antigen and peptide antigen within the binding groove ofvated cell sorting and Northern analyses. LPS-mediated inhibi-
tion of class II MHC in this setting was effected through a the major histocompatibility complex (MHC) molecule,
decrease in class II transactivator mRNA levels in treated F1K this trimolecular interaction is insufficient for complete
cells. By contrast, IFN-g and LPS coincubation induced B7-1 triggering of T-cell activation and effector function [4].but not B7-2 expression in F1K cells, as detected by Northern
Costimulatory molecules contribute to T-cell activationanalysis, flow cytometry, and immunoprecipitation. In addition,
by increasing or stabilizing adhesion between the T cellrenal tubular staining for B7-1 was apparent in kidneys isolated
from IFN-g1LPS-treated recipient mice, as well as mice with and the APC and by transmitting signals that augment
autoimmune glomerulonephritis. Further studies evaluated the TCR-mediated activation signals [4]. A number of rele-
interaction of F1K cells and MR1.3, a nephritogenic CD41
vant costimulatory molecules, such as CD28, CTLA-4,Th2 clone derived from kidneys of animals with autoimmune
B7-1, and B7-2, have been extensively characterized withglomerulonephritis. Cytokine production assays revealed that
F1K cells activated MR1.3 cells if they were pretreated with regards to their potential regulatory role in cell-mediated
both IFN-g and LPS 48 hours prior to exposure to nephrito- responses in autoimmune and allograft responses [4, 5].
genic T cells. Although CD28 and CTLA-4 are expressed almost ex-Conclusions. These studies are the first description of a dif-
clusively on T cells, their counter receptors, B7-1 andferential regulation of class II MHC and B7-1 expression in
B7-2, are expressed on a variety of cell types [6]. Consti-renal tubular epithelial cells mediated by IFN-g and LPS. Such
findings indicate that discrete proinflammatory stimuli could tutively expressed on dendritic cells, B7-1 and B7-2 are
potentiate antigen-presenting capabilities of renal tubular epi- up-regulated on activated macrophages and B cells [7].
thelial cells in vivo and further suggest a direct role of such
More recent in vitro studies indicate that these costimula-
tory molecules can also be induced on fibroblasts,
astrocytes, and some epithelial cells by proinflammatoryKey words: T lymphocytes, major histocompatibility complex, lipo-
polysaccharide, cytokines, interferon-g. stimuli [8–10].
A number of investigations have suggested that renal
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tected in vitro, with significant up-regulation by the pro- F1K epithelial cells
inflammatory cytokine interferon (IFN)-g, a cytokine Primary renal TECs, called F1K cells, were harvested
generated by activated T cells [13, 14]. Moreover, in from naive B6D2 F1 mouse kidneys following microdis-
situ analysis of kidneys with lupus nephritis, allograft section and brief collagenase digestion [28]. After Per-
rejection, and graft-versus-host disease reveals marked coll-density sedimentation, F1K cells were grown on type
cell-surface expression of class II MHC on TECs in areas I collagen-coated flasks in hormonally defined K-1 se-
of mononuclear cell infiltration and damage [15–18]. rum-free medium [28]. Expression of epithelial cell
Like professional APCs, renal TECs can be induced to markers (cytokeratin and uvomorulin) was verified by
express intercellular adhesion molecule-1 (ICAM-1) and immunofluorescence studies of subconfluent monolayers
vascular cell adhesion molecule-1 (VCAM-1), but costi- (data not shown). F1K cells were maintained in a Dulbec-
mulatory molecule B7-1 and B7-2 expression in such
co’s modified Eagle’s medium (DMEM) high-glucosesettings have not been well characterized [19, 20]. Ex-
medium (GIBCO BRL, Gaithersburg, MD, USA) withpression of B7-1 or B7-2 has been shown to increase
glutamine, antibiotics (penicillin and streptomycin), andprofoundly an APC’s ability to stimulate resting T cells
5% NuSerum (Beckton Dickinson Labware, Bedford,[21]. Transfection studies demonstrate that either B7-1
MA, USA). Cells were cultured at 378C in a humidifiedor B7-2 expression confers costimulatory function to
5% CO2 incubator.nonprofessional APCs in vitro [22, 23]. The relevance of
such up-regulated B7-1/B7-2 expression in vivo has been T cells
suggested by recent reports of local increases in expres-
MR1.3 T cells were isolated from nephritic kidneys ofsion in areas of tissue inflammation and damage [24, 25].
B6D2 F1 mice with cGVHD 14 weeks following diseaseWe have examined the antigen-presenting potential
induction [27]. T cells were maintained by weekly pas-of renal TECs in the context of murine chronic graft-
sage with 0.5 3 106 cells/ml irradiated (2500 rads) B6D2versus-host disease (cGVHD), a model of autoimmune
F1 spleen cells, and 10 U/ml human recombinantglomerulonephritis [26]. We investigated the ability of
interleukin-2 (IL-2; Boehringer Mannheim Corp., India-proinflammatory cytokine-stimulated TECs to activate
napolis, IN, USA). T-cell culture medium consists ofa renal antigen-specific CD41 Th2 clone, MR1.3, derived
Dulbecco’s modified Eagle’s high-glucose medium sup-from kidneys of animals with cGVHD [27]. Previous
plemented with glutamine, antibiotics (penicillin, strep-studies demonstrated that MR1.3 adoptively transfers
tomycin, and gentamicin), 10% decomplemented fetalrenal inflammation and damage to naive syngeneic recip-
ients [27]. Our studies reveal differential regulation of calf serum (FCS), 5% NCTCE (Whittaker Bioproducts,
class II MHC and B7-1/B7-2 expression in a murine renal Inc., Walkersville, MD, USA), and 2 3 1025 m 2-ME.
TEC line, called F1K, mediated by IFN-g and lipopoly- Cells were cultured at 378C in a humidified 5% CO2
saccharide (LPS). Cotreatment with IFN-g and LPS sig- incubator.
nificantly decreased the IFN-g–induced class II MHC
B8A.1 cellsand class II transactivator (CIITA) expression on F1K
cells. Of note, B7-1, but not B7-2, expression was induced B8A.1 is an L929 clone that was stably transfected with
on F1K cells with simultaneous exposure to IFN-g and murine B7-1 cDNA (kindly provided by Larry Turka,
LPS. Renal tubular expression of B7-1 was also detected University of Pennsylvania, Philadelphia, PA, USA).
in kidneys of mice treated with IFN-g and LPS and with These cells were isolated and propagated in selective
autoimmune glomerulonephritis. Further in vitro studies media (G418 1 mg/ml; Boehringer Mannheim Corp.)
revealed that following IFN-g and LPS treatment, F1K containing DMEM-high-glucose medium supplemented
cells activated CD41 nephritogenic Th2 cells, a response with glutamine, antibiotics (penicillin and streptomycin),
that was blocked by anti–B7-1 antibodies. These studies and 10% decomplemented FCS. B8A.1 cells were
demonstrate that TECs exposed to proinflammatory cy-
screened for high level of cell-surface murine B7-1 ex-tokines have the capacity to present renal antigen to
pression by flow cytometry prior to their use in experi-previously activated nephritogenic T-cell clones, and
ments. Cells were cultured at 378C in a humidified 5%suggest that TECs may have a crucial role in initiating
CO2 incubator.or propagating renal damage through interactions with
autoreactive T cells. T-cell–depleted antigen-presenting cells
Single-cell suspensions were prepared from naive
METHODS B6D2 F1 mouse spleens. Following red blood cell (RBC)
Mice lysis with Tris-ammonium-chloride, T cells were depleted
from cell preparations by incubation with anti–Thy-1.2Female (C57BL/6 3 DBA/2) F1 (B6D2 F1; H-2b/d)
antibody (PharMingen Inc., San Diego, CA, USA) andand DBA/2 (H-2d) were purchased from the Jackson
Laboratory (Bar Harbor, ME, USA). rabbit C (GIBCO BRL) at 378C [29]. Washed cell prepa-
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rations were then cultured under various experimental collected by centrifugation and washed twice with tris,
ethylene glycol, NaCl, triton X-100 buffer (TENT) bufferconditions at a density of 2.5 3 106 cells/ml.
and twice with Na dodecyl sulfate, ethylene glycol, tris
Additives (NET) buffer. SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) sample buffer was added directly to theRecombinant murine IFN-g (PharMingen) and LPS
from Escherichia coli serotype 026:B6 (Sigma Chemical pellets of immunoprecipitates and reduced with 10%
2-ME, and the samples were boiled for six minutes beforeCo., St. Louis, MO, USA) were used for stimulation of
F1K cells, T-cell–depleted APC preparations, and intra- analysis by SDS-PAGE (10%). After electrophoretic
transfer to nitrocellulose membrane (MSI, Westboro,peritoneal injections of B6D2 F1 mice.
MA, USA), blocking was carried out using 5% nonfat
RNA extraction and Northern hybridization analysis dry milk in Tris buffered saline-Tween 20 (TBS-T) for
30 minutes at room temperature. Blots were washed withTotal cellular RNA was isolated using Trizol reagent
(GIBCO BRL) in accordance with the manufacturer’s TBS-T, and immunoprecipitated biotinylated proteins
were detected by incubation with streptavidin-horserad-instructions. After assessing purity of final products by
OD ratios at 260/280 nm, which were typically 1.6 to 1.8, ish peroxidase (GIBCO BRL) in TBS-T (1:1000) for 90
minutes at room temperature. After washing with TBS-RNA samples were then used for Northern blot analysis.
Fifteen micrograms of total RNA per sample were elec- T, protein detection was carried out using the ECLE
protein detection system (Amersham Life Science Inc.,trophoresed through a 1.5% agarose-formaldehyde gel,
which was then transferred to a Zetabind membrane Arlington Heights, IL, USA) according to the manufac-
turer’s instructions.(Cuno Laboratory Products, Meriden, CT, USA). Blots
were hybridized to 32P (NEN Life Science Products, Bos-
Flow cytometryton, MA, USA)-labeled murine probes (specific activity
of 2.0 3 109 dpm/mg) for 16 hours at 658C. Murine probes, Single-cell suspensions were prepared by harvesting
F1K cells from subconfluent T-75 flasks. Cells were thenB7-1 (kindly provided by Dr. Larry A. Turka, University
of Pennsylvania), B7-2 [30], ICAM-1 (obtained from washed in ice-cold PBS/1% bovine serum albumin (BSA)
and 5 mm ethylenediaminetetraacetic acid (EDTA), pHAmerican Type Culture Collection, Rockville, MD,
USA) [31], I-Aa, I-Ea (kindly provided by Dr. Ronald 8.0 (staining buffer). Aliquots of 1 3 106 cells were resus-
pended in 50 ml staining buffer. Direct staining for B7-1Germain, NIAI), interleukin (IL)-4 [32], CIITA [33],
and b-actin [34] were used in these studies. After hybrid- was performed with a primary PE-conjugated anti–B7-1
(16-10A1; PharMingen) or PE-conjugated isotype-ization, the blots were washed in 0.1 3 standard saline
citrate/0.1% sodium dodecyl sulfate (SDS) at 658C for matched control antibody (PharMingen) for 20 minutes
on ice. Indirect staining for B7-2 and class II MHC wasone hour. Autoradiography was performed with intensi-
fying screens at 2708C. performed with primary anti–B7-2 antibody (GL1; Phar-
Mingen), anti–I-Ab antibody (AF6-120.1; PharMingen),
Cell surface biotinylation, immunoprecipitation, and or isotype-matched control antibodies (PharMingen) for
Western blot analysis 20 minutes on ice. Washed cells were then incubated a
second time on ice with appropriate secondary antibod-Confluent cell preparations were washed three times
with phosphate-buffered saline (PBS), and aliquots of ies, either goat anti-rat IgG-FITC (PharMingen) or goat
anti-mouse IgG-FITC (Boehringer Mannheim). Stained10 3 106 cells were resuspended in 0.2 mg/ml Sulfo-NHS-
Biotin (Pierce, Rockford, IL, USA) in PBS. All steps of cells were then washed and resuspended in staining
buffer. Two mg/ml propidium iodide (PI; Sigma Chemicalcell-surface biotinylation and immunoprecipitation were
performed on ice as described previously [35]. After 20 Co.) were added to cell suspensions, and fluorescence
was recorded on a FACScan cytofluorograph (Bectonminutes, 15 mm glycine in PBS were added to stop the
reaction, and the cells were washed three times with Dickinson and Co., Mountain View, CA, USA). Data
were analyzed with CELL Quest software. In each run,PBS. Cell lysis was then carried out for 30 minutes with
cell lysis buffer. Following isolation of soluble lysates by at least 10,000 (PI-excluded) gated events were analyzed.
centrifugation (14,000 3 g) for 20 minutes, the lysates
Kidney preparationswere precleared by incubation with a 1:1 (vol/vol) slurry
of protein A sepharose (Pharmacia Biotech, Uppsala, Some kidneys were harvested from B6D2 F1 mice
three days following a single dose of IFN-g (10,000 units;Sweden)/dilution buffer overnight at 48C. Supernatants
were collected by centrifugation (14,000 3 g) for 30 sec- PharMingen) and LPS (400 mg; Sigma). Additional kid-
neys were isolated from B6D2 F1 mice with cGVHD 6onds, incubated with 5 mg anti–B7-1 antibody (16-10A1;
PharMingen) for three hours, and then incubated with 1:1 to 10 weeks after the induction of disease [27]. Disease
was induced in six- to eight-week-old female B6D2 F1slurry of protein A sepharose/dilution buffer (4 ml/mg
antibody) for two hours at 48C. Immunoprecipitates were mice following transfer of 100 3 106 T cells derived from
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spleen, lymph node, and thymus preparations of six- to PharMingen). Following 45 minutes of incubation, the
eight-week-old female DBA/2 mice [27]. Following the plates were washed, coated with 100 ml aliquots of avidin-
induction of disease with parental DBA/2 T cells, animals peroxidase (1:400; Sigma), and incubated again at room
were evaluated every two weeks for urinary protein ex- temperature for 30 minutes. After a final wash, 100 ml
cretion using the Bio-Rad assay (Bio-Rad Laboratories, aliquots of peroxidase substrate reagent (Bio-Rad Labo-
Richmond, CA, USA) with a BSA standard. ratories) were added to each well and read on an ELISA
plate reader at 415 nm. The sensitivity limit for the IL-4
Immunohistochemistry ELISA was 30 pg/ml.
Frozen kidney sections were stained for B7-1 expres-
Statistical analysission (PharMingen) using the avidin-biotin-peroxidase
complex, ABC technique (Vector Laboratories, Burl- Differences between experimental groups were deter-
ingame, CA, USA). Frozen sections were fixed in chilled mined by Student’s t-test, where appropriate [36].
(2208C) acetone, air dried, then rehydrated in PBS. Fol-
lowing exposure to 0.3% H2O2 for 30 minutes, sections
RESULTSwere incubated with 5% goat serum in 3% BSA/PBS
for 30 minutes and then with an Avidin-Biotin blocking Modulation of class II major histocompatibility
reagent (Vector Laboratories) for 30 minutes. Appro- complex expression on F1K cells by interferon-g
priate dilutions of the primary antibody were applied, and lipopolysaccharide
and the slides were incubated for 60 minutes. Slides were To examine inducible class II MHC expression in iso-
washed in PBS and then incubated with biotinylated goat lated renal TECs, we exposed F1K cells to a series of
antihamster IgG (Vector Laboratories) for 60 minutes. timed proinflammatory stimuli. Under baseline condi-
Following another PBS wash, slides were incubated with tions, class II MHC (I-Ada) message expression was notthe Vectastain ABC reagent (Vector Laboratories) for detected in unstimulated F1K cells by Northern analysis
an additional 30 minutes. Slides were then incubated (Fig. 1A). As anticipated, IFN-g (100 U/ml) markedly
with diaminobenzidine (Vector Laboratories) and coun- up-regulated F1K cell class II MHC (I-Ada) messageterstained with hematoxylin (Fisher Scientific, Medford, expression (Fig. 1A). Figure 1A also reveals that class
MA, USA). Control sections consisted of staining with
II MHC message expression was apparent at 24 hours,
an irrelevant primary antibody (hamster IgG).
was markedly increased at 48 hours, and remained ele-
vated for several days after F1K cell exposure to IFN-g.T-cell activation assays
Similar Northern hybridization findings were obtainedT-cell stimulation was assessed by measuring IL-4 cy-
for I-Eda message expression in IFN-g–treated F1K cellstokine production in cell-free supernatants of CD41 Th2
(data not shown).clone MR1.3 exposed to various APC preparations. Day
By contrast, coincubation of F1K cells with two proin-10 MR1.3 T cells (1 to 1.5 3 106 cells/well) were cultured
flammatory stimuli, both IFN-g (100 U/ml) and LPS (10with renal antigen (10 mg/ml) for 24 hours with F1K cells
mg/ml), prevented maximal IFN-g–induced class II MHC(0.5 3 106 cells/well), irradiated (2500 rads) syngeneic
message expression (Fig. 1B). As shown in Figure 1B,B6D2 F1 spleen cells (0.5 3 106 cells/well), or T-cell
F1K cell stimulation with LPS at a dose of 10 mg/ml didmedium alone. Some F1K preparations were pretreated
not induce I-Ada mRNA expression. In addition, thewith IFN-g (100 U/ml) or IFN-g1LPS (10 mg/ml) for
exposure of F1K cells to higher doses of LPS (50 to 10048 hours prior to exposure to T cells. For some studies,
mg/ml) did not effect class II MHC expression (dataanti–B7-1 (10 mg/ml, 1G10; PharMingen) or rat IgG (10
not shown). Further evaluation of I-Ada Northern blotsmg/ml; Pierce) was added to F1K cell preparations 30
revealed that relative mRNA levels in IFN-g1LPS-minutes prior to adding MR1.3 T cells. IL-4 production
treated F1K cells were decreased at 24 and 48 hoursby MR1.3 T cells was measured in supernatants collected
following exposure, attaining only 25% of the maximalat 24 hours by cytokine-specific enzyme-linked immuno-
induced response by IFN-g at 48 hours (Fig. 1C).sorbent assay (ELISA) [29]. Purified anti–IL-4 capture
Further fluorescence-activated cell sorting (FACS)monoclonal antibody (PharMingen) was diluted to 1.0
analyses assessed class II MHC expression on the cell-mg/ml in 0.1 m NaHCO3, pH 8.2, and 50 ml aliquots were
surface of F1K cells treated with various experimentaladded to wells of an ELISA plate. Following overnight
conditions for 48 hours. Flow cytometry did not detectincubation at 48C and washing with PBS/0.05% Tween,
cell-surface class II MHC expression on either unstimu-wells were blocked with 200 ml PBS/5% FCS at room
lated or LPS-treated F1K cells (Fig. 2A). By contrast,temperature for two hours. Plates were then washed
IFN-g–stimulated F1K cells displayed an increase in classand coated with 50 ml samples. Plates were incubated
II MHC expression (Fig. 2B). Consistent with our North-overnight at 48C, washed, and coated with 100 ml aliquots
of biotinylated anti–IL-4 detecting antibody (1 mg/ml; ern hybridization data, however, this induced I-A expres-
Fig. 1. Modulation of class II major histocompatibility complex (MHC)
expression on F1K cells by interferon (IFN)-g and lipopolysaccharide
(LPS). F1K cells were cultured under a variety of conditions for distinct
time intervals. Harvested total RNA was evaluated for class II MHC
mRNA expression with a murine I-Ada cDNA probe. The b-actin signal
reflects relative amount of RNA loaded in each lane. (A) Time course
of class II MHC expression in IFN-g–treated F1K cells. (B) Class II
MHC expression in F1K cells stimulated with IFN-g (100 U/ml), LPS
(10 mg/ml), and both IFN-g and LPS. (C) Values for I-Ada mRNA were
normalized to levels of b-actin mRNA expression, by densitometric
analysis, and were plotted as a percentage of maximal response observed
in IFN-g–treated F1K cells at 48 hours. Symbols are: ( ) IFN-g; (j)
IFN-g 1 LPS. The presented findings are representative of three distinct
experiments.
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Fig. 2. FACS analysis of class II major histocompatibility complex (MHC) expression on stimulated F1K cells. Confluent F1K cells were incubated
with no additives, interferon (IFN)-g (100 U/ml), lipopolysaccharide (LPS; 10 mg/ml), or both IFN-g and LPS for 48 hours. Harvested F1K cells
were then analyzed by flow cytometry with an anti–I-Ab antibody (AF6-120.1). (A) Comparison of unstimulated F1K cells (heavy solid line) with
LPS-treated F1K cells (light solid line); the dotted line represents unstimulated F1K cells stained with isotype control antibody. (B) Comparison
of unstimulated F1K cells (dashed line) with IFN-g–treated (heavy solid line) and IFN-g and LPS-treated F1K cells (light solid line).
sion was down-regulated at 48 hours by simultaneous scripts (2.2 and 3.9 kb) in IFN-g1LPS-stimulated cells
that were identical in size to those observed in LPS-exposure of F1K cells to both IFN-g and LPS (Fig. 2B).
To examine potential mechanisms of LPS-mediated treated T-cell–depleted spleen cells (data not shown).
Figure 4A reveals that F1K cell B7-1 message expressionmodulation of class II MHC observed in these studies,
we evaluated the expression of CIITA in cytokine-stimu- was apparent 12 hours after stimulation, reaching a peak
lated F1K cells. As shown in Figure 3, CIITA expression 24 hours after coincubation with IFN-g and LPS (Fig.
was undetectable in untreated F1K cells, but is apparent 4A). Similar Northern hybridization studies evaluating
16 hours after IFN-g exposure. Coincubation of F1K cells B7-2 message expression in unstimulated and stimulated
with IFN-g and LPS, however, inhibited IFN-g–induced F1K cells did not detect inducible B7-2 costimulatory
CIITA mRNA expression by approximately 60%. These molecule expression (Fig. 4B).
studies indicate that LPS-mediated effects on class II To examine cell-surface expression of B7-1 and B7-2
MHC expression in renal TECs result from inhibition costimulatory molecules further, we performed FACS
of this intermediate protein. analysis of both unstimulated and stimulated F1K cells.
As shown in Figure 5, unstimulated F1K cells did not
Inducible B7-1 expression in renal tubular express either B7-1 or B7-2 glycoproteins. Simultaneous
epithelial cells exposure of F1K cells to IFN-g and LPS treatment for
48 hours, however, induced cell-surface expression ofTo evaluate the expression of costimulatory molecules
in renal parenchymal cells in the setting of IFN-g and B7-1 (Fig. 5A). B7-2 expression was not apparent in
similarly stimulated F1K cells (Fig. 5B). The increaseLPS cotreatment, we evaluated ICAM-1, B7-1, and B7-2
expression in stimulated F1K cells. Consistent with previ- noted in B7-1 cell-surface expression on F1K cells at 48
hours after exposure to IFN-g and LPS is consistent withous observations of renal TECs, IFN-g (100 U/ml) up-
regulated ICAM-l mRNA and cell-surface expression our Northern hybridization studies that exhibited peak
B7-1 message expression at 24 hours following stimula-on F1K cells at 24 and 48 hours, respectively, and was
further increased by simultaneous exposure to IFN-g tion (Fig. 4A). These findings suggest that IFN-g1LPS-
induced B7-1 expression in F1K cells is controlled, atand LPS (10 mg/ml; data not shown) [37]. As shown in
the Northern blot in Figure 4A, unstimulated F1K cells least partially, by the level of gene transcription or mes-
sage stability.and F1K cells stimulated with IFN-g or LPS alone do not
express B7-1. By contrast, IFN-g and LPS coincubation Immunoprecipitation experiments were also performed
to assess B7-1 protein expression on IFN-g1LPS-treatedinduces B7-1 expression in F1K cells. These Northern
hybridization studies detected two B7-1 mRNA tran- F1K cells. For these studies, unstimulated and IFN-g1
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that B7-1 gene and gene product expression are induced
by simultaneous F1K cell exposure to IFN-g and LPS.
To examine the relevance of cytokine stimulation to
immune recognition in vivo, we performed an immuno-
histochemical analysis of renal B7-1 expression in kid-
neys derived from IFN-g1LPS-treated mice, as well as
mice with cGVHD. As shown in Figure 7A, renal tubular
staining for B7-1 was apparent three days following a
single dose of IFN-g and LPS. A further analysis of B7-1
expression in kidneys of animals with cGVHD at various
time points after induction of disease revealed renal tu-
bular B7-1 expression at six to eight weeks after the
induction of autoimmune glomerulonephritis (Fig. 7D).
Mice with cGVHD had proteinuria and extensive glo-
merular immune deposits (data not shown) at six to eight
weeks after disease induction, but had not yet developed
significant tubulointerstitial inflammation and damage
(Fig. 7F).
IFN-g1LPS-stimulated F1K cells activate
nephritogenic T cells
To examine the functional relevance of enhanced B7-1
costimulatory molecule expression, we performed T-cell
activation assays with IFN-g1LPS-treated F1K cells and
MR1.3, a nephritogenic CD41 Th2 clone derived from
kidneys of animals with cGVHD [27]. Previous studies
demonstrated that MR1.3 recognizes renal antigen in
the context of I-Ad and adoptively transfers renal in-
flammation and damage to naive syngeneic recipients
[27]. The studies presented in Figure 8 reveal suboptimal
Fig. 3. Class II transactivator (CIITA) expression in cytokine-treated cytokine responses at 24 hours in assays with MR1.3 and
F1K cells. Total RNA was harvested from untreated F1K cells, F1K unstimulated F1K cells, or IFN-g–stimulated F1K cells,
treated with IFN-g (100 U/ml) for 16 hours, and F1K treated with
compared with maximal responses with MR1.3 and irra-IFN-g 1 LPS (10 mg/ml) for 16 hours, and analyzed by Northern hybrid-
ization with a murine CIITA cDNA probe. The b-actin signal reflects diated syngeneic spleen cells. Densitometric analysis of
the relative amount of RNA loaded in each lane. These presented the Northern blot in Figure 8A further revealed that
findings are representative of three separate experiments.
IL-4 mRNA levels from MR1.3 and unstimulated F1K
cells, and MR1.3 and IFN-g–stimulated F1K cells were
only 15% of the maximal responses noted with MR1.3
and irradiated syngeneic spleen cells. IL-4 production at
LPS-stimulated F1K cells were surface-biotinylated, 24 hours was markedly augmented, however, in assays
lysed, and exposed to an anti–B7-1 antibody. Lysates of with MR1.3 cells and IFN-g1LPS-treated F1K cells,
surface-biotinylated control B7-1 transfectant fibroblasts, with a fourfold increase in IL-4 mRNA and secreted
B8A.1, which constitutively express high levels of B7-1, cytokine expression (Fig. 8). These results indicate that
were also evaluated. Previous studies have demonstrated simultaneous IFN-g and LPS treatment potentiates the
that 16-10A1, the anti–B7-1 antibody employed in these antigen-presenting function of F1K cells in vitro.
studies, immunoprecipitates a protein with an approxi- Further studies with blocking anti–B7-1 antibodies
mate mass of 60 kDa from murine cells [38]. As shown evaluated the specific role of B7/CD28-mediated costim-
in Figure 6 A and B, the anti–B7-1 antibody immunopre- ulatory signals in MR1.3 activation induced by IFN-g1
cipitated a molecule with an apparent molecular mass LPS-treated F1K cells. To ensure that blockade was pri-
of 60 kDa from B8A.1 cells and from IFN-g1LPS-stimu- marily at the APC level, anti–B7-1 antibodies were
lated F1K cells. This 60 kDa band was not apparent, added to F1K cell preparations 30 minutes before adding
however, in anti–B7-1 antibody immunoprecipitates from MR1.3 T cells. As shown in Figure 9, T-cell activation
unstimulated F1K (Fig. 6B). In aggregate, these flow induced by IFN-g1LPS-treated F1K cells was markedly
cytometry and immunoprecipitation studies verify the diminished by anti–B7-1 antibodies, as IL-4 production
was reduced to levels observed in the untreated F1K cellinitial Northern hybridization analyses and demonstrate
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Fig. 4. Inducible B7 expression on stimulated
F1K cells. For these studies, F1K cells and
T-cell–depleted spleen cells were cultured for
defined intervals with no additives, lipopoly-
saccharide (LPS; 10 mg/ml), interferon (IFN)-g
(100 U/ml), or both IFN-g and LPS. Total
RNA harvested from discrete cell prepara-
tions was analyzed by Northern hybridization
with a murine B7-1 cDNA probe (A) or a
murine B7-2 cDNA probe (B). The b-actin
signal reflects the relative amount of RNA
loaded in each lane. Presented findings are
representative of three separate experiments.
mRNA and cell-surface protein expression on F1K cells
and suggest a significant functional role in renal TEC-
induced T-cell activation.
DISCUSSION
The studies presented here describe differential regu-
lation of class II MHC and B7-1 costimulatory molecule
expression in murine renal TECs mediated by simultane-
ous exposure to IFN-g and LPS. We observed that
IFN-g–induced MHC and CIITA expression in F1K cells
is markedly diminished by simultaneous exposure to
LPS. Despite a decrease in class II MHC expression,
however, IFN-g and LPS stimulation induced B7-1 co-
stimulatory molecule expression in F1K cells. B7-2 ex-
pression in F1K cells was not detected under these exper-
imental conditions. Immunohistochemical analysis of
kidneys from IFN-g1LPS-treated mice or cGVHD mice
revealed that renal TEC expression of B7-1 was induced
under such proinflammatory conditions in vivo. Cytokine
production analyses demonstrated that IFN-g1LPS-
stimulated F1K cells provided relevant costimulatory
molecule activation signals to MR1.3, a nephritogenic
CD41 Th2 clone isolated from diseased kidneys of mice
with cGVHD. These findings indicate that proinflamma-
tory stimuli could potentiate APC function of renal TECs
group. Similarly conducted studies with control rat IgG in vivo and further suggest a direct role for resident renal
had no effect on MR1.3 activation in these studies. These parenchymal cells in modulating immune responses in
data are consistent with our finding that early responses the kidney.
Renal TEC expression of class II MHC has been evalu-to simultaneous IFN-g and LPS treatment affect B7-1
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Fig. 5. FACS analysis of B7 expression on stimulated F1K cells. Confluent F1K cells or lipopolysaccharide (LPS)-stimulated (T cell-depleted)
splenocytes were incubated in the presence or absence of interferon (IFN)-g (100 U/ml) and LPS (10 mg/ml) for 48 hours. Harvested F1K cells
were then analyzed by flow cytometry using (A) anti–B7-1 antibody (16-10A1) and (B) anti–B7-2 antibody (GL1). Presented findings are
representative of three separate experiments. Lines in A represent (dashed line) unstimulated F1K; (heavy solid line) F1K 1 IFN-g 1 LPS; (light
solid line) spenocytes 1 LPS. Lines in B represent: (dashed line) unstimulated F1K; (solid heavy line) F1K 1 IFN-g 1 LPS; (light solid line)
spenocytes 1 LPS.
and nonprofessional APCs have also been well-described
[39]. LPS treatment in vivo up-regulates class II MHC
expression primarily via IFN-g–mediated pathways, as
concomitant administration of IFN-g–neutralizing anti-
bodies inhibit MHC expression [40]. The effects of con-
current IFN-g and LPS exposure on professional APC
class II MHC expression in vitro, however, are less
straightforward [39, 41]. Studies of murine peritoneal
macrophages indicate that simultaneous IFN-g and LPS
exposure inhibits induced class II MHC expression [41,
42]. This LPS-induced suppression of class II MHC ex-
pression is associated with decreased transcription of
both I-A and I-E genes [42, 43]. By contrast, induced
class II MHC expression is augmented if LPS is delivered
Fig. 6. Immunoprecipitation of B7-1 from interferon (IFN)-g 1 lipo- more than 12 hours after IFN-g exposure [42, 43]. Inter-polysaccharide (LPS)-treated F1K cells. For these studies, confluent
estingly, studies of other proinflammatory cytokines,cells were incubated in medium alone or with IFN-g (100 U/ml) and
LPS (10 mg/ml) for 48 hours. Following cell-surface biotinylation and such as tumor necrosis factor-a and IL-1b, also reveal
lysis, immunoprecipitation was performed with an anti–B7-1 antibody. similar inhibitory effects on professional APC class IIImmunoprecipitates were analyzed by SDS-PAGE (10%) under reduc-
MHC gene expression [44, 45].ing conditions. (A) B8A.1 cells, unstimulated (L929 clone stably trans-
fected with murine B7-1 cDNA). (B) F1K cells, unstimulated. (C) F1K Our current observations are the first description of
cells, stimulated with IFN-g (100 U/ml) 1 LPS (10 mg/ml).
this down-regulation in renal TECs and indicate that
IFN-g and LPS cotreatment has a similar regulatory ef-
fect on class II MHC expression in murine TECs in vitro.
These studies also suggest that LPS-mediated inhibitionated both in vitro and in vivo [11, 13, 39]. Although
of class II MHC expression is effected through sup-there is some variability in reports of its constitutive
pressed class II MHC transcription, as IFN-g and LPSexpression, all studies reveal marked up-regulation fol-
exposure blocks up-regulation of the class II MHC trans-lowing proinflammatory stimuli such as IFN-g exposure
activator in F1K cells. These observations are consistent[11, 13, 39]. The proinflammatory effects of IFN-g and
LPS on class II MHC expression in both professional with the notion that class II MHC expression in nonpro-
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Fig. 7. Renal B7-1 expression in recipient mice. Kidneys harvested from B6D2 F1 mice were evaluated immunohistochemically for B7-1 expression.
Kidneys were examined three days after treatment with interferon (IFN)-g (10,000 units) and lipopolysaccharide (LPS; 400 mg) (A–C) or seven
weeks after induction of chronic graft vs. host disease (cGVHD; D–F). Immunoperoxidase staining on renal tubular epithelial cells is apparent in
sections incubated with anti–B7-1 antibody (16-10A1; A, D), but not the irrelevant control antibody (B, E). Representative hematoxylin and eosin
staining of relevant kidney sections is shown in C and F (A–F 3100).
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Fig. 8. Interferon (IFN)-g- 1 lipopolysaccharide (LPS)-treated F1K
cells activate MR1.3 T cells. MR1.3 T cells (1 3 106 cells/well) and renal
antigen (10 mg/ml) were cultured for 24 hours with T-cell medium alone,
with F1K cells (0.5 3 106 cells/well), or with irradiated syngeneic B6D2
F1 spleen cells (0.5 3 106 cells/well). Some F1K cells were pretreated
for 48 hours with IFN-g (100 U/ml) or LPS (10 mg/ml) 1 IFN-g (100
U/ml). IL-4 expression was used as a measure of T-cell activation. (A)
Northern hybridization with a radiolabeled murine IL-4 probe. Lane 1,
unstimulated F1K cells; lane 2, unstimulated F1K cells and MR1.3;
lane 3, IFN-g-stimulated F1K cells and MR1.3; lane 4, IFN-g 1 LPS-
stimulated F1K cells and MR1.3; lane 5, irradiated B6D2 F1 spleen
cells and MR1.3. (B) IL-4 production in cell-free supernatants was also
measured. Results are presented as a mean of three experiments 6 sd.
*P , 0.05 vs. F1K 1 MR1.3 and vs. F1K 1 IFN-g 1 MR1.3.
fessional APCs, like renal TECs, results from a sequence
of locally delivered signals at sites of inflammation. Such
down-regulation of parenchymal class II MHC expres-
sion may reflect modulation of host immune responses
by mediators such as LPS in the setting of many proin-
flammatory stimuli.
Multiple investigators have reported that renal TEC
preparations present both self and foreign antigen to
T-cell hybridomas and CD41 T-cell clones in vitro [11–
13]. Studies with antigen-specific clones, however, indi-
cate that renal TECs do not stimulate Th1 cell prolifera-
tion, despite inducing T-cell enlargement and increased
IL-2 receptor expression [46]. Relevant costimulatory
molecules in such TEC/T-cell interactions have not been
well defined [46–48]. Previous analyses of proinflamma-
tory cytokine TEC activation reveal that many cell-sur-Fig. 9. Maximal MR1.3 activation by interferon (IFN)-g 1 lipopolysac-
face molecules such as ICAM-1, VCAM-1, and heat sta-charide (LPS)-treated F1K cells requires B7-1. MR1.3 T cells (1 3 106
cells/well) and renal antigen (10 mg/ml) were cultured for 24 hours with ble antigen are up-regulated along with class II MHC
either untreated F1K cells (0.5 3 106 cells/well), IFN-g 1 LPS-treated expression [19, 20, 48]. Similar increased TEC expressionF1K cells, IFN-g 1 LPS-treated F1K cells with anti–B7-1 antibody (10
of these molecules has also been detected in vivo inmg/ml), or IFN-g 1 LPS-treated F1K cells with control Ig (10 mg/ml).
IL-4 production was used as a measure of T-cell activation. Results are conditions such as lupus nephritis [19, 20]. It is notewor-
presented as a percentage of maximal IL-4 production observed in the
thy, however, that TECs expressing high levels of bothIFN-g 1 LPS-treated F1K cell group without antibody (mean of three
experiments 6 sd). *P , 0.01 vs. control rat Ig group. class II MHC and ICAM-1 do not uniformly activate
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all subsets of CD41 T cells [46–48]. Although relevant Nephrol 8:540, 1997; Weiss, J Am Soc Nephrol 7:1725,
1996; Deng et al, J Am Soc Nephrol 7:1696, 1996) [46,costimulatory molecules expressed by TECs in CD41
T-cell studies reported to date have not been delineated, 48]. The disparity of reported TEC B7-1/B7-2 expression
in various studies perhaps indicates that these costimula-these studies suggest that distinct costimulatory mole-
cules on TECs can provide costimulation to at least dis- tory molecules have distinct species- or strain-dependent
regulatory pathways for expression in TECs that arecrete subsets of CD41 T cells [3].
In addition to the effects on class II MHC expression, perhaps altered by in vitro culture conditions. Our stud-
ies verify that unstimulated or IFN-g–stimulated primaryrecent studies indicate that both IFN-g and LPS are
potent inducers of B7-1 and B7-2 costimulatory mole- murine TECs do not express B7 costimulatory molecules
and do not provide optimal nephritogenic Th2 clonecules in murine B cells and macrophages [7, 38, 49]. As
previously described, B7 costimulatory molecules are costimulation. In addition, we observed that B7-1 up-
regulation in renal TECs requires both IFN-g and LPScritical for activation of some CD41 T cells [50]. Further
in vitro analyses of inducible B7-1/B7-2 expression in exposure and requires 48 hours for maximal cell-surface
expression and function. Moreover, renal TEC expres-distinct subsets of nonprofessional APCs have provided
intriguing observations regarding the expression of these sion of B7-1 was detected in vivo under distinct experi-
mental conditions in these studies. We observed renalmolecules in settings of organ-specific inflammation [8–
10, 44, 51]. Studies of gastric epithelial cells, intestinal tubular staining of B7-1 in mice treated with both IFN-g
and LPS, as well as in animals with cGVHD. It is interest-smooth muscle cells, fibroblasts, astrocytes, and micro-
glial cells all reveal inducible B7-1 or B7-2 expression ing that B7-1 expression in this model of autoimmune
glomerulonephritis was apparent early in the course ofin these nonprofessional APCs [8–10, 44, 51]. These co-
stimulatory molecules are up-regulated with proinflam- disease (6 to 8 weeks) when mice are proteinuric and
have glomerular immune deposits but have not devel-matory mediators such as IFN-g, tumor necrosis factor-a,
or LPS [8–10, 44, 51]. Moreover, pretreated cell prepara- oped significant tubulointerstitial pathology. This sug-
gests that augmented renal tubular B7-1 expression maytions provide effective costimulation to discrete CD41 T
cells in proliferation assays, suggesting a functional rele- be an early event in initiating tubulointerstitial injury
and inflammation.vance of such costimulatory molecule expression in vivo
[8–10, 44, 51]. Our studies also demonstrate that IFN-g1LPS-stimu-
lated TECs activate a nephritogenic CD41 Th2 clone inOur current studies reveal that IFN-g and LPS cotreat-
ment is unique in its ability to induce B7-1 expression the presence of renal antigen. Previous studies demon-
strate that this renal-derived, I-Ad–reactive Th2 clone,on primary murine renal TECs. These findings further
suggest that distinct regulatory mechanisms control B7-1 MR1.3, induces severe tubulointerstitial injury on adop-
tive transfer to naive syngeneic recipients [27]. Our cur-and B7-2 gene expression in nonprofessional APCs such
as renal TECs. Previous studies examining the effect of rent observations indicate that renal TEC up-regulation
of B7-1 can provide relevant costimulation to nephrito-IFN-g and LPS cotreatment on class II MHC and B7-2
expression in professional APCs indicate a differential genic T-cell clones in vitro and suggest a functional sig-
nificance of these interactions in vivo. It is interestingregulatory effect of such cotreatment on expression of
these molecules in murine peritoneal macrophages [6, 7]. that despite the proscriptive influence of LPS on IFN-
g–induced class II MHC expression in these studies, F1KIt is interesting that these proinflammatory stimuli also
differentially modulate class II MHC and B7-1 expres- cells remained competent APCs for nephritogenic T
cells. Such findings suggest that renal TECs can effectsion in TECs. This observation suggests noncoordinated
expression of class II MHC and B7-1 may occur in TECs APC function, even in the setting of low-level class II
MHC expression, if relevant costimulatory moleculesin vivo, depending on locally released inflammatory me-
diators and the sequence of signaling at the site of in- (B7-1) are appropriately up-regulated.
Recent investigations of T-cell clone B7 requirementsflammation. In addition, our studies did not detect B7-2
expression in TECs under these particular experimental indicate that memory and effector T cells appear to have
less stringent requirements for activation than naive cellsconditions. This observation indicates that B7-2 is not
inducible in TECs with proinflammatory cytokine stimu- [50, 52]. Both of these T-cell populations respond to
some extent to TCR stimulation alone and demonstratelation or, alternatively, that in vitro culture conditions
may affect regulation of B7-2 expression in TECs. less dependency on costimulatory signals than naive T
cells [50, 52]. Minimal cytokine release and moderateAlthough some investigators have not detected consti-
tutive or inducible B7 costimulatory molecule expression proliferation are induced from memory cells stimulated
with plate-bound anti-CD3 antibodies in the absence ofin renal TECs, both B7-1 and B7-2 have been reported
in recent published abstracts of primary-cultured and additional stimulation [50, 52, 53]. Overall, in vitro stud-
ies indicate that Th1 cell IL-2 production appears moretransformed TEC lines under distinct experimental con-
ditions (abstracts; Madrigal-Estabas et al, J Am Soc dependent on costimulatory molecule expression than
Banu and Meyers: Differential regulation of class II MHC and B7-12262
2. Lan HY, Paterson DJ, Atkins RC: Initiation and evolution ofother Th subsets [50, 52, 53]. In addition, previous analy-
interstitial leukocytic infiltration in experimental glomerulonephri-
ses revealed that T cell anergy, ignorance, or prolifera- tis. Kidney Int 40:425–433, 1991
tion (in the presence of suboptimal doses of immobilized 3. Meyers CM: T-cell regulation of renal immune responses. Curr
Opin Nephrol 4:270–276, 1995anti-CD3 antibodies) is induced in Th1 cells coincubated
4. Collins TL, Kassner PD, Bierer BE, Burakoff SJ: Adhesionwith B7-1 transfected renal TECs [46, 47]. receptors in lymphocyte activation. Curr Opin Immunol 6:385–393,
Examination of Th2 costimulatory requirements for 1994
5. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7cytokine secretion suggests that, unlike Th1 cell IL-2
and CD28 receptor families. Immunol Today 17:321–331, 1994secretion, other cytokines can be induced in effector T 6. Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ: Com-
cells without accessory molecule involvement [50, 53, parative analysis of B7-1 and B7-2 costimulatory ligands: Expres-
sion and function. J Exp Med 180:631–640, 199454]. Th2 secretion of these cytokines, such as IL-4 or
7. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system ofIL-5, however, is enhanced in the presence of such mole- T cell costimulation. Annu Rev Immunol 14:233–258, 1996
cules [50, 53]. Our studies evaluating Th2 (MR1.3) IL-4 8. Nikcevich KM, Gordon KB, Tan L, Hurst SD, Kroepfl JF,
Gardinier M, Barrett TA, Miller SD: IFN-g-activated primaryproduction in this study are consistent with these obser-
murine astrocytes express B7 costimulatory molecules and primevations, in that IL-4 production is submaximal in the naive antigen-specific T cells. J Immunol 158:614–621, 1997
absence of induced B7-1 expression on renal TECs. 9. Pechhold K, Patterson NB, Craighead N, Lee KP, June CH,
Harlan DM: Inflammatory cytokines IFN-g plus TNF-a induceMoreover, this response is inhibited in the presence of
regulated expression of CD80 (B7-1) but not CD86 (B7-2) onanti–B7-1 antibodies. Unlike the functional findings re-
murine fibroblasts. J Immunol 158:4921–4929, 1997
ported for Th1 cells and B7-1 transfected TECs, these 10. Ye G, Barrera C, Fan X, Gourley WK, Crowe SE, Ernst PB,
Reyes VE: Expression of B7-1 and B7-2 costimulatory moleculesTh2 cell interactions with primary renal TECs induce
by human gastric epithelial cells. J Clin Invest 99:1628–1636, 1997predominantly activation signals (cytokine production)
11. Haverty TP, Kelly CJ, Hines WH, Amenta PS, Watanabe M,
[47]. Disparate requirements and responses to B7-1– Harper RA, Kefalides NA, Neilson EG: Characterization of a
renal tubular epithelial cell line which secretes the autologousexpressing epithelial cells may underlie different T-cell–
target antigen of autoimmune experimental interstitial nephritis.mediated immune responses in the kidney. Events that
J Cell Biol 107:1359–1368, 1988
induce or indeed inhibit interstitial inflammation and 12. Hagerty DT, Allen PM: Processing and presentation of self and
injury in autoimmune glomerulonephritis have not been foreign antigens by the renal proximal tubule. J Immunol 148:2324–
2330, 1992clearly elucidated. In view of such observations, induced
13. Wuthrich RP, Glimcher LH, Yui MA, Jevnikar AM, Dumasrenal TEC B7-1 costimulatory molecule expression in SE, Kelley VE: MHC class II, antigen presentation and tumor
vivo may play an important immunomodulatory role in necrosis factor in renal tubular epithelial cells. Kidney Int 37:783–
792, 1990either initiating or down-regulating injurious renal im-
14. Haverty TP, Watanabe M, Neilson EG, Kelly CJ: Protectivemune responses. modulation of class II MHC gene expression in tubular epithelium
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